UNICA IRIS Institutional Research Information System

CRISPONI, GUIDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 182.288
NA - Nord America 14.244
AS - Asia 5.342
SA - Sud America 773
Continente sconosciuto - Info sul continente non disponibili 420
AF - Africa 116
OC - Oceania 15
Totale 203.198
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 175.766
US - Stati Uniti d'America 14.029
NL - Olanda 2.944
SG - Singapore 2.058
CN - Cina 1.964
UA - Ucraina 1.128
SE - Svezia 639
BR - Brasile 595
DE - Germania 512
FI - Finlandia 419
VN - Vietnam 399
GB - Regno Unito 339
FR - Francia 281
KR - Corea 156
IN - India 144
HK - Hong Kong 139
CA - Canada 135
BD - Bangladesh 127
AR - Argentina 64
RU - Federazione Russa 57
ES - Italia 44
MX - Messico 41
IQ - Iraq 40
TR - Turchia 40
JP - Giappone 38
IR - Iran 33
ID - Indonesia 28
BE - Belgio 26
EC - Ecuador 26
AT - Austria 23
ZA - Sudafrica 22
PK - Pakistan 21
PL - Polonia 21
PH - Filippine 20
CO - Colombia 19
UZ - Uzbekistan 18
CL - Cile 16
MA - Marocco 16
SA - Arabia Saudita 16
TN - Tunisia 16
AU - Australia 15
CH - Svizzera 15
JM - Giamaica 15
MY - Malesia 15
EG - Egitto 13
UY - Uruguay 13
VE - Venezuela 13
PE - Perù 12
SY - Repubblica araba siriana 11
IE - Irlanda 10
DZ - Algeria 9
KE - Kenya 9
PY - Paraguay 9
TH - Thailandia 9
CR - Costa Rica 8
NG - Nigeria 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
CZ - Repubblica Ceca 7
JO - Giordania 7
MU - Mauritius 7
RO - Romania 7
BG - Bulgaria 6
ET - Etiopia 6
IL - Israele 6
BO - Bolivia 5
GR - Grecia 5
MD - Moldavia 5
NP - Nepal 5
PT - Portogallo 5
SK - Slovacchia (Repubblica Slovacca) 5
AM - Armenia 4
BY - Bielorussia 4
LB - Libano 4
PS - Palestinian Territory 4
RS - Serbia 4
CI - Costa d'Avorio 3
GT - Guatemala 3
IS - Islanda 3
KZ - Kazakistan 3
LT - Lituania 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AL - Albania 2
BB - Barbados 2
BH - Bahrain 2
BW - Botswana 2
EE - Estonia 2
EU - Europa 2
GD - Grenada 2
GE - Georgia 2
HU - Ungheria 2
KG - Kirghizistan 2
KH - Cambogia 2
MN - Mongolia 2
NO - Norvegia 2
PA - Panama 2
SN - Senegal 2
SV - El Salvador 2
BN - Brunei Darussalam 1
Totale 202.767
Salva come PNG Salva come JPEG
Città #
Cagliari 172.329
Amsterdam 2.923
Uta 2.568
Fairfield 1.440
Ashburn 1.120
Woodbridge 1.072
Singapore 967
Houston 813
San Jose 798
Chandler 767
Dallas 630
Jacksonville 610
Wilmington 610
Ann Arbor 597
Boardman 595
Seattle 557
Cambridge 508
Nyköping 439
Dearborn 295
Beijing 269
Helsinki 237
Los Angeles 231
Council Bluffs 202
Nanjing 197
Hefei 183
Lauterbourg 170
Boston 162
Seoul 145
The Dalles 141
Santa Clara 139
Ho Chi Minh City 132
Hong Kong 129
New York 124
Hanoi 106
Buffalo 96
Shanghai 92
San Diego 72
Nanchang 70
Escalaplano 69
Milan 69
Guangzhou 67
São Paulo 58
Shenyang 56
Hebei 52
Redwood City 52
Tianjin 50
Toronto 49
Changsha 47
Atlanta 44
Jiaxing 43
Columbus 42
Redondo Beach 39
Verona 37
Orem 36
Mountain View 34
Norwalk 33
London 32
Dong Ket 30
Zhengzhou 30
Orange 29
Chicago 28
Sassari 28
Frankfurt am Main 27
Ottawa 27
Tokyo 27
Brussels 26
Jinan 26
Rome 26
Brooklyn 24
Chennai 24
Ningbo 22
Pune 22
Washington 22
Rio de Janeiro 20
Auburn Hills 17
Hangzhou 17
Nuremberg 17
Phoenix 17
Cedar Knolls 16
Pars 16
San Francisco 16
Tashkent 15
Warsaw 15
Haiphong 14
Bari 13
Da Nang 13
Manchester 13
Naples 13
Stockholm 13
Curitiba 12
Turku 12
Baghdad 11
Charlotte 11
Dhaka 11
Falls Church 11
Mumbai 11
Wuhan 11
Belo Horizonte 10
Bologna 10
Florence 10
Totale 194.227
Salva come PNG Salva come JPEG
Nome #
Iron Chelation for Iron Overload in Thalassemia 5.751
A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity 3.858
Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one 3.639
Complex formation equilibria of Cu2 + and Zn2 + with Irbesartan and Losartan 3.553
para-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metabolite 3.543
Multiple Sclerosis and environmental factors. 3.300
Metal coordination and tyrosinase inhibition studies with Kojic-βAla-Kojic 2.960
Sampling variability in hepatic iron concentration in beta-thalassemia 2.873
Searching for new aluminium chelating agents: a family of hydroxypyrone ligands 2.802
The essential metals for humans: a brief overview 2.709
Looking at new ligands for chelation therapy 2.567
A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies 2.445
A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays 2.416
Kojic acid derivatives as powerful chelators for iron(III) and aluminium(III) 2.304
Gold nanoparticles: A new golden Era in oncology? 2.279
Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives 2.235
A review on coordination properties of thiol-containing chelating agents towards mercury, cadmium, and lead 2.231
Do anti-diabetic drugs act as copper ligands? 2.214
Toxicity of nanoparticles: etiology and mechanisms 2.158
New strong extrafunctionalizable tris(3,4-HP) and bis(3,4-HP) metal sequestering agents: synthesis, solution and in vivo metal chelation 2.119
Arsenic toxicity: Molecular targets and therapeutic agents 2.082
Equilibrium studies of new bis-hydroxypyrone derivatives with Fe3+, Al3+, Cu2+ and Zn2+ 2.077
Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators 2.044
Complex formation equilibria of polyamine ligands with copper(II) and zinc(II) 2.032
Chelation therapy for metal intoxication. Comments from a thermodynamic view point 1.979
Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds 1.970
Editorial: Applications of Medicinal Bioinorganic Chemistry 1.960
The meaning of aluminium exposure on human health and aluminium-related diseases 1.936
Kill or cure: Misuse of chelation therapy for human diseases 1.929
A new hydroxypyrone powerful chelator. From synthesis to AlIII, FeIII, CuII and ZnII complex formation equilibria, and structural characterization 1.902
Substituent effects on ionization constants as a predictive tool of coordinating ability 1.896
Silver coordination compounds: A new horizon in medicine 1.876
Alarming use of chelation therapy 1.853
Iron III and aluminium III complexes with substituted salicyl-aldehydes and salicylic acids 1.840
Chemical features of in use and in progress chelators for iron overload 1.830
Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions 1.827
(5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl3-({[(5-hydroxy-4-oxo-4H-pyran-2-yl)methoxy] carbonyl}amino) propanoate. Synthesis and its complex formation study 1.806
Comparison of selectivity of a family of chelating agents for trivalent (Al3+, Fe3+) and bivalent (Cu2+, Zn2+) metal ions 1.800
State of art in chelating agents for the clinical treatment of metal poisoning 1.796
Noble metals in medicine: Latest advances 1.792
An NMR study on the 6,6'-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with Al(III) and Zn(II) ions 1.784
Hydroxypyrones, an intriguing family of chelating agents for Fe(III) and Al(III) 1.769
A speciation study on the perturbing effects of iron chelators on the homeostasis of essential metal ions 1.743
A family of hydroxypyrone ligands designed and synthesized for iron chelators 1.715
Chelating agents as therapeutic compounds - Basic principles 1.713
The Role of Magnesium in Pregnancy and in Fetal Programming of Adult Diseases 1.686
Uneven hepatic iron and phosphorus distribution in b-thalassemia 1.661
Uneven hepatic copper distribution in Wilson's disease 1.625
Chelating agents for human diseases related to aluminium overload 1.563
Uneven cardiac iron distribution in beta-thalassemia 1.515
Pyridoxamine driven selective turn-off detection of picric acid using glutathione stabilized fluorescent copper nanoclusters and its applications with chemically modified cellulose strips 1.424
Three-in-one type fluorescent sensor based on a pyrene pyridoxal cascade for the selective detection of Zn(ii), hydrogen phosphate and cysteine 1.355
Chelating agents for metal intoxication 1.310
The Potential Clinical Properties of Magnesium 1.308
Metal ion toxicity 1.243
Iron chelating agents for iron overload diseases 1.241
Analytical determination of total acidity in some Sardinian wines: evaluation of the contribute of different acids 1.240
Insights on alpha lipoic and dihydrolipoic acids as promising scavengers of oxidative stress and possible chelators in mercury toxicology 1.214
Warns against unapproved ‘chelation therapy’ 1.207
null 1.188
Substituent effects on ionisation and 13C NMR properties of some monosubstituted phenols. A potentiometric, spectrophotometric and 13C NMR study 1.171
Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach 1.166
Metal ions in the pathogenesis of Alzheimer’s disease: an open field 1.163
The aging kidney—as influenced by heavy metal exposure and selenium supplementation 1.119
Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites 1.116
Chemometric methods applied to an ICP-AES study of chemical element distributions in autopsy livers from subjects affected by Wilson’s disease and beta-thalassemia 1.096
null 1.075
Substituent effect on the stability of iron(III)-salicylate complexes. Structure of trans-[Fe(H5Nsal) 2(H2O)2]Cl·2H2O 1.072
A new hydroxypyrone chelating agent for FeIII and AlIII: a structural and equilibrium study 1.061
Potentiometric and spectrophotometric equilibrium study on Fe(III) and new catechol-bisphosphonate conjugates 1.060
Kojic derivatives: a promising class of iron(III) chelators 1.006
A spectroscopic study on ionization of 2-, 3- and 4-aminopyridines 990
Chelating Agents in Soil Remediation: A New Method for a Pragmatic Choice of the Right Chelator 972
Enhancement of g-aminobutyric acid binding by Quazepam, a benzodiazepine derivative with preferential affinity for type I benzodiazepine receptors 964
The outer/inner sphere dichotomy in the reaction of some adenine-like N-ligands with [Cu(H2EDTA)(H2O)] chelate 923
Different approaches to the study of chelating agents for iron and aluminium overload pathologies 905
Aluminium dependent human diseases, and chelating properties of aluminium chelators for bio-medical applications 897
Nickel binding sites in histone proteins: spectroscopic and structural characterization 885
A Chemometric analysis of metal ion content in Sardinian wines 860
null 845
Manganese and cobalt binding in a multi-histidinic fragment 839
Preface 820
Anomalies of the oral cavity in newborns 783
Stress and ß-carbolines decrease the density of low affinity Gaba binding sites; an effect reversed by diazepam 780
Complex formation equilibria of copper(II) with triethylentetramine and its human acetyl metabolites 771
Calculation of spectra parameters in several spectra by contemporary decomposition in the constituent Gaussian peaks 763
Divalent metal-acetate complexes in concentrated aqueous solutions. An X-ray diffraction and NMR spectroscopy study 750
Changes in the characteristics of low affinity of Gaba binding sites elicited by Ro15-1788 726
Structural correlations in nickel(II)-thiodiacetato complexes: molecular and crystal structures and properties of [Ni(tda)(H2O)(3)] 724
SUBSTITUENT EFFECTS OF NITRO GROUP ON THE COMPLEX FORMATION EQUILIBRIA OF SALICYLIC ACID AND CATECHOL WITH Fe(III) AND Al(III) IONS 713
Brain copper, iron, magnesium, zinc, calcium, sulfur and phosphorus storage in Wilson's disease 704
Bisphosphonate chelating agents: complexation of Fe(III) and Al(III) by 1-phenyl-1-hydroxymethylene bisphosphonate and its analogues 697
Thiodiacetato-copper(II) chelates with or without N-heterocyclic donor ligands: molecular and/or crystal structures of [Cu(tda)](n), [Cu(tda)(Him)(2)(H2O)] and [Cu(tda)(5Mphen)] center dot 2H(2)O (Him = imidazole, 5Mphen=5-methyl-1,10-phenanthroline) 688
Equilibrium constants of the Fe(III)dopamine system in aqueous solution 688
Chemometric methods applied to an ICP-AES study of chemical element distributions in autopsy livers from subjects affected by Wilson and beta-thalassemia 688
null 678
A windmill-shaped hexacopper(II) molecule built up by template core-controlled expansion of diaquatetrais(mu(2)-adeninato-N3,N9)dicopper(II) with aqua(oxydiacetato)copper(II) 669
null 666
Uneven element distribution in alcoholic liver disease. A case report 649
THIODIACETATE-COPPER(II) CHELATES WITH OR WITHOUT N-HETEROCYCLIC DONOR LIGANDS. CRYSTAL STRUCTURES OF [CU(TDA)]N, [CU(TDA)(HIM)2(H2O)] AND [CU(TDA)(5MPHEN)].2H2O 642
Totale 160.471
Salva come PNG Salva come JPEG
Categoria #
all - tutte 280.039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 280.039
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.458 0 959 497 772 751 678 521 326 596 687 881 790
2022/202311.356 922 1.154 1.175 826 942 1.268 548 1.937 802 571 719 492
2023/202412.856 746 532 575 997 1.394 2.210 1.777 829 517 1.068 1.120 1.091
2024/202528.715 7.253 7.466 3.352 2.552 1.431 1.515 2.380 203 420 1.370 319 454
2025/202611.294 563 379 1.242 736 530 708 1.920 658 2.798 863 614 283
2026/2027581 135 446 0 0 0 0 0 0 0 0 0 0
Totale 203.198